318 Berk/DeMarzo, Corporate Finance, Fourth Edition, Global Edition
©2017 Pearson Education, Ltd.
( )
buy 36
571 1
NPV 15,800 1 $1,749.48 m
0.00881 1.00881
= − + − =
The expected value of replacing the cabs in year 5 is:
EV = (0.5)(7,249.48 + 1,749.48) = $4,499.48 m
The value today of this:
( )
buy 60
4, 499.48
PV $2,658.23 m
1.00881
==
Adding this to the NPV of leasing from part a gives:
22–23. Genenco is developing a new drug that will slow the aging process. In order to succeed, two
breakthroughs are needed, one to increase the potency of the drug, and the second to eliminate
toxic side effects. Research to improve the drug’s potency is expected to require an upfront
investment of $10 million and take 2 years; the drug has a 5% chance of success. Reducing the
drug’s toxicity will require a $30 million up-front investment, take 4 years, and has a 20%
chance of success. If both efforts are successful, Genenco can sell the patent for the drug to a
major drug company for $2 billion. All risk is idiosyncratic, and the risk-free rate is 6%.
a. What is the NPV of launching both research efforts simultaneously?
b. What is the optimal order to stage the investments?
c. What is the NPV with the optimal staging?
22–24. Your engineers are developing a new product to launch next year that will require both software
and hardware innovations. The software team requests a budget of $6 million and forecasts an
80% chance of success. The hardware team requests a $11 million budget and forecasts a 53%
chance of success. Both teams will need 6 months to work on the product, and the risk-free
interest rate is 3% APR with semiannual compounding.
a. Which team should work on the project first?
b. Suppose that before anyone has worked on the project, the hardware team comes back and
revises their proposal, changing the estimated chance of success to 78% based on new
information. Will this affect your decision in (a)?